Celltrion launches 2026 biotech scale-up program with Japan’s KBIC

Verifying
  • Celltrion announced a joint startup program with Japan’s Kobe Biomedical Innovation Cluster.
  • Two companies will be selected in March next year after applications, screening and presentations.
  • Selected startups will receive customized incubation throughout 2027, according to Celltrion’s program plan.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.